Patent · US Active

Monoclonal antibodies targeting killer immunoglobulin-like receptor (KIR) family signaling

US10858431B2 · kind B2 · utility

0Cited by

1References

7Claims

0Family size

Assignee

Trellis Bioscience, Inc. · US

Inventors

Angeles Estelles · Belmont, US
Mikhail Gishizky · Palo Alto, US
Stefan RYSER · Menlo Park, US
Lawrence M. Kauvar · San Francisco, US

Key dates

Filing date	Jun 9, 2017
Grant date	Dec 8, 2020
Priority date	—
Expiry date	May 15, 2038

Classification

Technology area (CPC C)Chemistry; Metallurgy
CPC primaryC07K2317/92
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

Monoclonal antibodies derived from the native human repertoire that bind the extracellular portion of Killer IgG Receptor (KIR) and pharmaceutical and veterinary compositions thereof are useful in treating cancer in human and other subjects.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.